Drugmaker Says FDA Delayed OK Of Narcolepsy Medication
A drug developer is suing the U.S. Department of Health and Human Services over its yearlong delay in approving a newer and allegedly more efficient narcolepsy drug amid a fight over whether...To view the full article, register now.
Already a subscriber? Click here to view full article